Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

  • There is currently no data for CAU

Trading Update

10 Oct 2024 07:00

RNS Number : 6181H
Centaur Media PLC
10 October 2024
 

Centaur Media plc

Incorporated in England and Wales

Registration number: 04948078

LEI: 2138005WK87G7DQRQI62

ISIN: GB0034291418

 

10 October 2024

Centaur Media Plc

("Centaur" or "the Company")

 

Trading Update

 

Centaur, an international provider of business intelligence, learning and specialist consultancy, provides a trading update.

 

As highlighted in the interim results in July, the marketing sector headwinds caused by macro-economic challenges have continued to drive restructurings in the marketing functions of many blue-chip customers of Xeim. This has led to the curtailment of marketing budgets and, although we have retained most of these customers, their spend has reduced. The prolonged impact of these challenges is materially reducing revenue and profit during the second half of 2024.

 

These headwinds are having a significant impact on Xeim's Econsultancy and Oystercatchers brands, and Xeim's non-strategic advertising revenue. More positively, revenue from our future growth drivers, The Lawyer, MW Mini MBA, Festival of Marketing's October event and Marketing Week's subscriptions, has continued to improve in the second half.

 

EBITDA in 2024 will decline as a result of the impact of the high operational gearing on Xeim's lower revenue and a change in revenue mix. EBITDA will also be lower than last year due to the 2024 planned £1.3m investment in product, marketing and resources set out in our BIG27 strategy. This will accelerate the growth of our strategically valuable revenue over the next three years, in particular from The Lawyer, MW Mini MBA and Marketing Week's subscriptions.

 

The Board now expects the Company to achieve revenue of at least £34m in 2024, at an adjusted EBITDA margin of approximately 15%, which is significantly below the current analyst consensus range. This revised expectation will also impact our revenue and profit expectations in 2025.

 

Outlook

We continue to review our go-to-market plans and maintain a focus on robust cost management. We retain a cautious outlook and do not anticipate that trading conditions for the affected parts of our business will improve in the near term.

 

Nonetheless, Centaur's strong balance sheet, with £9.5m of net cash at 30 September 2024, and reliable cash conversion from our strategically valuable revenue streams, means that we are well positioned to manage this uncertainty. We will also continue to invest behind our strategy, as this will generate long-term value, while maintaining our progressive dividend policy which, as previously announced, is paying an interim ordinary dividend of 0.6 pence per share later this month.

 

Enquiries

Centaur Media plc 020 7970 4000

Swag Mukerji, Chief Executive Officer

Simon Longfield, Chief Financial Officer

 

Teneo

 

Zoë Watt / Oliver Bell

07713 157561 / 07917 221748

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUKARRSRURRUA
Date   Source Headline
21st Apr 20268:00 amRNSCancellation - Centaur Media PLC
20th Apr 20265:52 pmRNSHolding(s) in Company
16th Apr 20269:41 amRNSHolding(s) in Company
16th Apr 20269:39 amRNSHolding(s) in Company
16th Apr 20269:37 amRNSHolding(s) in Company
16th Apr 20269:36 amRNSHolding(s) in Company
7th Apr 20265:45 pmRNSHolding(s) in Company
7th Apr 20267:00 amRNSHolding(s) in Company
1st Apr 20264:52 pmRNSHolding(s) in Company
1st Apr 20264:41 pmRNSHolding(s) in Company
31st Mar 20264:23 pmRNSHolding(s) in Company
31st Mar 202611:15 amRNSHolding(s) in Company
30th Mar 20264:44 pmRNSHolding(s) in Company
30th Mar 202611:19 amRNSHolding(s) in Company
30th Mar 202611:06 amRNSHolding(s) in Company
27th Mar 20262:30 pmRNSHolding(s) in Company
27th Mar 20262:09 pmRNSHolding(s) in Company
27th Mar 20262:09 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSResult of Tender Offer
23rd Mar 202612:08 pmRNSUpdate on Tender Offer
17th Mar 20261:25 pmRNSResult of Court Hearing
26th Feb 20267:00 amRNSResult of General Meeting
18th Feb 20267:00 amRNSStrategic Partnership
10th Feb 20262:44 pmRNSHolding(s) in Company
5th Feb 20263:59 pmRNSHolding(s) in Company
4th Feb 202611:24 amRNSHolding(s) in Company
30th Jan 20267:00 amRNSTender Offer
6th Jan 20267:00 amRNSTender offer update and sale of Econsultancy
24th Nov 202510:57 amRNSChange of Registered Office
29th Oct 20258:28 amRNSUpdate on Return of Capital
22nd Oct 20254:14 pmRNSHolding(s) in Company
22nd Oct 202512:03 pmRNSHolding(s) in Company
21st Oct 20254:39 pmRNSHolding(s) in Company
21st Oct 20252:12 pmRNSHolding(s) in Company
13th Oct 20257:00 amRNSDirector/PDMR Shareholding
9th Oct 20255:15 pmRNSDirector/PDMR Shareholding
8th Oct 20252:00 pmRNSSale of The Lawyer
25th Sep 20257:00 amRNSAgreement for the sale of Marketing Week
17th Sep 20257:00 amRNSInterim results for the 6 months ended 30 Jun 2025
11th Sep 20257:00 amRNSConditional agreement for the sale of The Lawyer
5th Sep 20252:00 pmRNSHolding(s) in Company
27th Aug 202512:30 pmRNSHolding(s) in Company
19th Aug 20259:39 amRNSHolding(s) in Company
18th Jul 202511:30 amRNSSale of MiniMBA and Notice of Results
25th Jun 20257:00 amRNSConditional agreement for the sale of MiniMBA
19th Jun 20257:00 amRNSExtension to Exclusivity
22nd May 202512:00 pmRNSDirector/PDMR Shareholding
9th May 20258:16 amRNSResponse to Media Speculation
8th May 202512:33 pmRNSResult of AGM
22nd Apr 202512:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.